BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24366883)

  • 21. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
    Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
    J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
    Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
    Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer.
    Roh JI; Lee J; Sung YH; Oh J; Hyeon DY; Kim Y; Lee S; Devkota S; Kim HJ; Park B; Nam T; Song Y; Kim Y; Hwang D; Lee HW
    Oncogene; 2020 Sep; 39(36):5876-5887. PubMed ID: 32728173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.
    Floyd HS; Farnsworth CL; Kock ND; Mizesko MC; Little JL; Dance ST; Everitt J; Tichelaar J; Whitsett JA; Miller MS
    Carcinogenesis; 2005 Dec; 26(12):2196-206. PubMed ID: 16051643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells.
    Symonds JM; Ohm AM; Tan AC; Reyland ME
    Oncotarget; 2016 Apr; 7(14):17905-19. PubMed ID: 26918447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CLPTM1L is overexpressed in lung cancer and associated with apoptosis.
    Ni Z; Tao K; Chen G; Chen Q; Tang J; Luo X; Yin P; Tang J; Wang X
    PLoS One; 2012; 7(12):e52598. PubMed ID: 23300716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy.
    Cai J; Li R; Xu X; Zhang L; Lian R; Fang L; Huang Y; Feng X; Liu X; Li X; Zhu X; Zhang H; Wu J; Zeng M; Song E; He Y; Yin Y; Li J; Li M
    Nat Cell Biol; 2018 Apr; 20(4):465-478. PubMed ID: 29593330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
    Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
    Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
    Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
    Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers.
    Konishi T; Huang CL; Adachi M; Taki T; Inufusa H; Kodama K; Kohno N; Miyake M
    Int J Oncol; 2000 Mar; 16(3):501-11. PubMed ID: 10675482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
    Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
    Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells.
    Man JH; Liang B; Gu YX; Zhou T; Li AL; Li T; Jin BF; Bai B; Zhang HY; Zhang WN; Li WH; Gong WL; Li HY; Zhang XM
    J Clin Invest; 2010 Aug; 120(8):2829-41. PubMed ID: 20628200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective requirement for Mediator MED23 in Ras-active lung cancer.
    Yang X; Zhao M; Xia M; Liu Y; Yan J; Ji H; Wang G
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2813-22. PubMed ID: 22988093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.
    Schmidt ML; Hobbing KR; Donninger H; Clark GJ
    Cancer Res; 2018 May; 78(10):2614-2623. PubMed ID: 29735543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
    Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
    Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement for Rac1 in a K-ras induced lung cancer in the mouse.
    Kissil JL; Walmsley MJ; Hanlon L; Haigis KM; Bender Kim CF; Sweet-Cordero A; Eckman MS; Tuveson DA; Capobianco AJ; Tybulewicz VL; Jacks T
    Cancer Res; 2007 Sep; 67(17):8089-94. PubMed ID: 17804720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
    Whitsett TG; Cheng E; Inge L; Asrani K; Jameson NM; Hostetter G; Weiss GJ; Kingsley CB; Loftus JC; Bremner R; Tran NL; Winkles JA
    Am J Pathol; 2012 Jul; 181(1):111-20. PubMed ID: 22634180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
    Winn RA; Marek L; Han SY; Rodriguez K; Rodriguez N; Hammond M; Van Scoyk M; Acosta H; Mirus J; Barry N; Bren-Mattison Y; Van Raay TJ; Nemenoff RA; Heasley LE
    J Biol Chem; 2005 May; 280(20):19625-34. PubMed ID: 15705594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.